BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Merck Accelerates Next-Generation Drug Discovery with Acquisition of HUB Organoids

HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fas...

December 19, 2024 | News

Everest Medicines’ VELSIPITY® Prescribed in Mainland China, Pioneering New Ulcerative Colitis Treatment under Hong Kong-Macau Connect

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

December 18, 2024 | News

25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine

Biopharma in 2025: AI Transforming Drug Discovery and Precision Medicine The biopharma landscape in 2025 is poised for an unprecedented transformation, dr...

December 13, 2024 | Analysis

CureGene Secures NMPA Approval for Clinical Trial of Novel Antiplatelet Drug CG-0255 in China

CureGene Pharmaceutical ("CureGene"), a biotechnology company dedicated to innovative treatments for critical unmet medical needs in cardio-cerebrovascular...

December 13, 2024 | News

Porton Pharma Solutions and Aojin Life Sciences Forge Strategic Partnership to Advance XDC Conjugate Drug Development

Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co., Ltd. ("Aojin Life Sciences"). Porton will...

December 13, 2024 | News

Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production

The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity&nb...

December 06, 2024 | News

Beckman Coulter Life Sciences Introduces Cydem VT System, Transforming Clone Screening for Biologics

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, and a company of Danaher Corporation (NYSE: DHR), launches the Cyde...

December 05, 2024 | News

Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

December 04, 2024 | News

Everest Medicines Reports Promising Phase 1b/2a Results for EVER001 in Primary Membranous Nephropathy

Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) ...

December 04, 2024 | News

ACROBiosystems' US Innovation Lab Secures ISO/IEC 17025 Accreditation for SPR Analytical Services

ACROBiosystems' US Innovation Lab has recently achieved ISO/IEC 17025 accreditation for its Surface Plasmon Resonance (SPR) analytical service, ensuring th...

December 03, 2024 | News

Everest Medicines’ New Drug Application for VELSIPITY® (etrasimod) Accepted in Hong Kong for Ulcerative Colitis

Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...

December 03, 2024 | News

India Becomes Third Country to Launch Dr. Reddy’s Toripalimab, a Next-Gen Immuno-Oncology Therapy

Dr. Reddy’s Laboratories Ltd., in collaboration with Shanghai Junshi Biosciences Co. Ltd., today announced the launch of Toripalimab under the brand ...

November 29, 2024 | News

China’s 2024 National Reimbursement Drug List Expands Access to Cutting-Edge Therapies

The National Healthcare Security Administration of China has unveiled the 2024 National Reimbursement Drug List (NRDL), incorporating several pioneering th...

November 29, 2024 | News

Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline

Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...

November 26, 2024 | News

Stay Connected